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Abstract 29 
The development of the eye in vertebrates is dependent upon glucocorticoid signalling, 30 
however, specific components of the eye are sensitive to synthetic glucocorticoids. The 31 
presence of synthetic glucocorticoids within the aquatic environment may therefore have 32 
important consequences for fish, which are heavily reliant upon vision for mediating several 33 
key behaviours. The potential ethological impact of synthetic glucocorticoid oculotoxicity 34 
however has yet to be studied. Physiological and behavioural responses which are dependent 35 
upon vision were selected to investigate the possible toxicity of prednisolone, a commonly 36 
occurring synthetic glucocorticoid within the environment, during early life stages of 37 
zebrafish. Although exposure to prednisolone did not alter the morphology of the external 38 
eye, aggregation of melanin within the skin in response to increasing light levels was 39 
impeded and embryos exposed to prednisolone (10 µg/l) maintained a darkened phenotype. 40 
Exposure to prednisolone also increased the preference of embryos for a dark environment 41 
within a light dark box test in a concentration dependent manner. However the ability of 42 
embryos to detect motion appeared unaffected by prednisolone. Therefore, while significant 43 
effects were detected in several processes mediated by vision, changes occurred in a manner 44 
which suggest that vision was in itself unaffected by prednisolone. Neurological and 45 
endocrinological changes during early ontogeny are considered as likely candidates for future 46 
investigation. 47 
 48 
Capsule 49 
Exposure to prednisolone alters physiological and behavioural responses to visual stimuli during 50 
zebrafish embryogenesis via proposed non-ocular mechanisms. 51 
 52 
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Introduction 62 
 63 
Autoimmune and inflammatory conditions e.g. asthma and arthritis, are routinely treated 64 
using a variety of synthetic glucocorticoid based therapies. However, these treatments are 65 
commonly associated with an increased rate of visual defects, including the development of 66 
cataracts and glaucoma.
1
 Exposure to synthetic glucocorticoids also affects specific ocular 67 
tissues in vitro and subsequently induces a range of abnormalities. Increased opacity of the 68 
lens, proptosis, unfused eyelids, epithelial defects at the lens and cornea, ocular hypotension 69 
and changes to the structure of trabecular meshwork cells are associated with synthetic 70 
glucocorticoid toxicity.
2,3
 The introduction of synthetic glucocorticoids within the aquatic 71 
environment
4,5,6
 via waste water effluent may therefore have a significant impact upon the 72 
visual system of fish which are dependent upon glucocorticoid signalling to mediate ocular 73 
development. Knockout of the GR transcript in zebrafish (Danio rerio) embryos causes a 74 
significant increase in crystalline proteins associated with development of the lens.
7
 GR 75 
morphants also display temporal changes in sox9b expression which plays a significant role 76 
in regulating the number of Müller glia and photoreceptor cells during neural retinogenesis in 77 
zebrafish.
8
 MMP14a, a matrix metalloproteinase (MMP), helps regulate retinal and 78 
retinotectal development
9
, however,  MMP expression is significantly affected by synthetic 79 
glucocorticoids in zebrafish
10-12
. Recent evidence has shown that prednisolone, a commonly 80 
detected synthetic glucocorticoid in the environment, significantly alters physiological 81 
processes during zebrafish development in a manner consistent with the effects of 82 
endogenous glucocorticoid signalling
13
. The potential behavioural impact of synthetic 83 
glucocorticoids on the visual system during ontogeny however has yet to be investigated in 84 
fish. 85 
 86 
Zebrafish provide an excellent model system to explore the potential ethological effects of 87 
synthetic glucocorticoids on the visual system. The development of the eye in zebrafish has 88 
already received considerable attention as a model to investigate visual processes and genetic 89 
disease in vertebrates.
14-16 
As such, the development of the eye
17-21
, the ontogeny of vision
22-90 
27
 and the onset of associated behaviours
27
 have been well categorised in zebrafish embryos 91 
and larvae.  92 
 93 
Behaviour has been increasingly utilised as a sensitive indicator of developmental change in 94 
response to contaminants
29
 and changes to visually mediated behaviours have been used 95 
extensively to assess the oculotoxicity of several contaminants in early life stages of 96 
zebrafish
30-33
. The eye first appears at around 10 hpf in zebrafish and the first visually 97 
mediated behaviours are evident from 70 hpf
19
 which facilitates rapid toxicological screening 98 
as several physiological and behavioural responses are principally mediated by vision during 99 
embryogenesis.  100 
 101 
The ability to alter skin pigmentation in response to changing light levels is believed to 102 
facilitate anti-predatory behaviour.
16
 This process is regulated by photoreceptors in the eye as 103 
well as those within the pineal gland and melanophores, however, the aggregation of pigment 104 
is principally mediated by vision
34
.  An absence of photoreceptors in the retina of eby and ivy 105 
zebrafish mutants is associated with an inability to aggregate melanin within the 106 
melanophores, resulting in extreme hyper-pigmented phenotypes.
35
 Similarly, the 107 
lakritz zebrafish mutant contains 80% less retinal ganglion cells within the retina, which are 108 
responsible for transmitting visual information to various areas of the brain, resulting in a 109 
darkened phenotype.
15
 Changes to the composition of the retina, in response to synthetic 110 
glucocorticoids, may therefore manifest externally during the light adaptation response.  111 
 112 
Changes to light sensitivity may also impact behaviour. The light-dark box test (LDBT), 113 
which has predominantly served as a means to assess anxiety, has been successfully applied 114 
in rodent models to evaluate differences in visually mediated behaviours
36
. Based upon an 115 
innate preference for either light or dark areas depending upon the design of the apparatus
37
, 116 
changes in preference for light over dark areas is hypothesised to facilitate vision
38
. Changes 117 
in the eye’s sensitivity to light may also be expected to reduce the perceived difference 118 
between light and dark areas. Similar tests have been used to investigate ocular toxicity in 119 
zebrafish.
31
  120 
 121 
The ability to detect motion develops early during zebrafish ontogeny and is necessary to 122 
allow prey tracking behaviour and predatory detection.
39,40
 Zebrafish embryos display 123 
characteristic avoidance behaviour in response to a moving object and may therefore be 124 
utilised to evaluate the ability of zebrafish embryos to detect motion. Pelkowski et al.
39
 and 125 
Richendrfer and Créton
41
 used simple animations consisting of basic shapes to induce 126 
avoidance reactions in early life stages of zebrafish. The ability to perceive movement 127 
requires the capacity to form images and to track their change in position over time and 128 
requires advanced visual processes which function in conjunction with the neurological 129 
system. Abnormal behavioural responses to moving stimuli have previously highlighted 130 
specific mutations in the neural circuitry and composition of the retina in zebrafish larvae.
15
  131 
 132 
Investigating the developmental effects of synthetic glucocorticoids on the visual system may 133 
not only reveal the impact of this class of compounds within an environmental context, but 134 
may also reveal specific sensory and neurological targets of synthetic glucocorticoids during 135 
early ontogeny in vertebrates. This study therefore investigated the effects of prednisolone on 136 
morphological, physiological and behavioural responses specifically associated with vision 137 
during early development in zebrafish. All experimental animals are herein referred to as 138 
embryos, in line with Balon's classification of early life stages, as all were pre-first feeding
42
.     139 
 140 
 141 
Methods 142 
 143 
Embryo collection and prednisolone exposure 144 
Adult zebrafish from an existing stock at the University of the West of Scotland (UWS) were 145 
maintained in 25 l glass aquaria (28±1°C; 12:12 light-dark) in a 400 l re-circulatory system. 146 
Fish were fed twice daily with flake (AQUARIAN) and once daily with Artemia sp. nauplii 147 
ad libitum. Males and females were separated prior to spawning when they were mixed 148 
within a breeding net, allowing collection of embryos.  Embryos were maintained in 50 ml of 149 
embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM MgSO4.7H20, 0.33 mM CaCl2.2H2O 150 
and 10
-5
% of methylene blue in distilled water)
43
 in 100 ml beakers kept in water baths 151 
(28±1°C; 8:16 light-dark). Any embryos which failed to develop normally during the 152 
experiment were removed daily. Groups of 50 embryos were exposed to 0.1, 1 and 10 µg/l of 153 
prednisolone (Sigma) dissolved in ethanol (0.01%, Analytical grade, Sigma) and were 154 
continually exposed following fertilisation (< 1 h) using static exposures with partial renewal 155 
(50%) every 24 h. Stock solutions were made daily prior to use and were kept at 4°C in the 156 
dark. Water and solvent controls were also tested. Experimental treatments were replicated 157 
four times (i.e. four beakers of each treatment) for morphometric analysis and three times for 158 
all other measurements.  159 
 160 
Chemical analysis 161 
Water samples were analysed at the University of Santiago de Compostela (USC), Spain via 162 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) using the previously 163 
published method for analysing pharmaceuticals including corticosteroids
44
. Please refer to 164 
McNeil et al. 2016
13
 for sample preparation and experimental conditions used. 165 
Concentrations of samples collected at 0 h were 0.1±0.05, 1.1±0.63 and 8.2±0.45 µg/l. No 166 
prednisolone was detected within either control group. Due to sample degradation while in 167 
transport between UWS and USC, chemical analysis of water samples collected at later time 168 
points is not provided as all samples were affected. Results are therefore discussed in terms of 169 
nominal concentrations of prednisolone at 0 h. 170 
 171 
Morphometric analysis 172 
Morphometric analysis of the outer eye was conducted at 72, 96 & 120 hpf. Embryos were 173 
anaesthetised in MS-222 and were photographed using a Leica MZFIII photo-microscope, 174 
connected to a digital camera. Images were then viewed in Image J.
45
 The area of the entire 175 
eye and pupil were calculated. Four embryos from four treatment replicates were 176 
photographed (n = 16). Preliminary tests were also conducted to investigate the potential 177 
changes to the opacity of the lens following prednisolone treatment. Lenses were removed 178 
from embryos at 120 hpf and were viewed microscopically. No visible morphological 179 
differences or changes to opacity were observed in response to any concentration of 180 
prednisolone and so no further analysis was conducted.  181 
 182 
Light adaptation 183 
Methods were modified from Shiraki et al.
34
 Embryos (96 hpf) were acclimated to darkness 184 
for 3 h during the 3
rd
 hour of their light cycle. This ensured all embryos had fully acclimated 185 
to darkness and reduced variation in skin pigmentation due to circadian rhythmicity. Embryos 186 
were mounted in 6% methylcellulose on microscope slides and were then returned to 187 
darkness for 30 min. Embryos were then positioned above a light source (500 lux, measured 188 
using a Dr. Meter LX1010BS digital lux meter) underneath a Leica MZFIII photo-189 
microscope connected to a digital camera. From here, a specific area of the embryo (Figure 1) 190 
was photographed at 0, 20 and 40 minutes post-light exposure. When not being 191 
photographed, embryos were continuously exposed to light conditions (500 lux). The change 192 
in the area of pigmentation was measured over time using Image J and compared between 193 
treatments. Four embryos from three treatment replicates were photographed (n = 12).  194 
 195 
Light-dark box test 196 
The light-dark box test was conducted at 120 hpf. The apparatus consisted of a 6 cm diameter 197 
petri dish marked with a grid floor (4.5 mm
2
; approx. one body length), equally divided into a 198 
white and black area. The floor of the dish was further divided into three circular areas (outer, 199 
middle & central). Individual embryos were initially acclimated within a small transparent 200 
chamber positioned within the central area for 1 minute before being allowed to explore the 201 
tank for 5 minutes. Behaviour was filmed using a JVC TH-C1480B colour camera positioned 202 
directly above the test apparatus. The entire apparatus and camera were screened from view 203 
using a curtain to prevent disturbance. The percentage of time spent in each compartment 204 
(light vs. dark), the proportion of time within each of the three circular areas within the light 205 
compartment and the total level of activity (total number of lines crossed) while in the white 206 
compartment was recorded. Four larvae from three treatment replicates were observed (n = 207 
12).  208 
 209 
Avoidance of visual stimulus 210 
Avoidance behaviour was tested at 144 hpf in response to an animated visual stimulus. 211 
Embryos were placed into individual wells of a six well plate containing embryo medium 212 
(28°C). The plate was positioned on top of a horizontal laptop screen and was filmed from 213 
above using a JVC TH-C1480B colour camera connected to a desktop PC. The visual 214 
stimulus was produced via the laptop using Microsoft PowerPoint and consisted of two black 215 
rectangles (0.4 x 14.6 cm) which were positioned parallel to one another. Each rectangle 216 
repeatedly moved forwards and backwards between the inner edge of one row of wells and 217 
the centre of the well (Figure 2), separating each well into an area with and without a moving 218 
black bar. Individuals were allowed to acclimate for 5 minutes on top of a white screen and 219 
then were recorded for 5 minutes before the presentation of the stimulus began. The 220 
animation was then played for 5 minutes. Afterwards, embryos were once again presented 221 
with a blank white background for 5 minutes. The amount of time embryos spent in the outer 222 
area of the well, which contained no visual stimulus, was calculated for each of three 5 223 
minute observation periods (pre-animation, during and post-animation). The latency to leave 224 
the inner area after the onset of the animation and the latency to re-enter the inner area after 225 
completion of the animation was also recorded. Methods were based on Richendrfer and 226 
Créton
41
 and were validated using a pilot study which found that the visual stimulus produced 227 
a significant avoidance reaction. Six embryos from three treatment replicates were observed 228 
(n = 18).  229 
 230 
Statistical analysis 231 
All statistical analysis was conducted using SPSS v.18. Data were checked for normality and 232 
homogeneity of variances using Kolmogorov-Smirnov and Levene’s tests, respectively. 233 
Where data were not normally distributed, or in the case of percentage data, transformations 234 
were conducted to allow parametric testing by ANOVA with Fisher’s LSD test post hoc. 235 
Non-parametric equivalents were used where necessary (Scheirer-Ray-Hare (SRH), Kruskal- 236 
Wallis test (KW) and pairwise Mann-Whitney U). No effect of beaker replicate was found for 237 
any of the variables tested and so replicates were combined for statistical analysis.  238 
 239 
 240 
Results 241 
 242 
Prednisolone exposure did not induce any superficial malformations during ontogeny at any 243 
of the observed stages of development. Nor did prednisolone treatment significantly affect 244 
the area of the entire eye or the area of the pupil.  245 
 246 
Exposure to all three concentrations of prednisolone resulted in significantly darker embryos 247 
from the onset of the light adaptation procedure (2-way ANOVA: Time,  P < 0.001, 248 
Treatment,  P < 0.001: Time*Treatment, P = 0.262, Figure 3).However, only those embryos 249 
exposed to 10 µg/l of prednisolone produced a sustained darkened phenotype throughout the 250 
entire 40 minutes of light exposure. There was no significant difference in the overall change 251 
in the area of pigmentation over the 40 minutes between treatments.  252 
 253 
Prednisolone also significantly affected the proportion of time spent in the dark area of the 254 
LDBT (ANOVA, P < 0.001, Figure 4). While exposure to 0.1 µg/l of prednisolone 255 
significantly reduced the percentage of time spent in the dark area, 10.0 µg/l of prednisolone 256 
significantly increased the proportion of time spent in the dark area. Exposure to 1.0 µg/l did 257 
not produce any significant change in preference compared to controls. Activity and the 258 
percentage of time spent in each of the three areas within the light compartment did not 259 
significantly vary between treatments.  260 
 261 
Individuals significantly increased the amount of time spent away from the moving image in 262 
the outer area of the plate (ANOVA, P < 0.001, Figure 5). No significant difference however 263 
was found between treatments. There were also no significant differences in the latency to 264 
move away from the moving stimulus (KW, χ²(4) = 2.521, P = 0.641) or in the latency to re-265 
enter the area in which presented the stimulus (KW, χ²(4) =1.552, P = 0.817). 266 
 267 
 268 
Discussion  269 
 270 
Exposure to environmentally relevant concentrations of prednisolone resulted in significant 271 
changes to physiological and behavioural parameters associated with vision during 272 
embryogenesis in zebrafish. However, evidence suggests these changes are not mediated by 273 
changes to vision directly. No superficial malformations or morphological changes were 274 
observed in the eyes of embryos exposed to any concentration of prednisolone.   275 
 276 
However, embryos exposed to 10 µg/l of prednisolone retained a significantly darker 277 
phenotype throughout the light adaptation period (Figure 3). Since the overall reduction in the 278 
area of dispersed pigment was not significantly different between treatments during the 40 279 
minute light exposure, embryos appear to be able to mediate skin colour at a rate comparable 280 
to controls, which suggests that the detection of light via photoreceptors within the eye is not 281 
detrimentally affected by prednisolone. Therefore the darkened phenotype of embryos 282 
exposed to 10 µg/l of prednisolone does not appear to be related to effects associated with 283 
vision but may in fact be related to changes to the melanogenic system. Melanin-284 
concentrating hormone (MCH) is responsible for the aggregation of melanin and works in 285 
conjunction with alpha-melanocyte stimulating hormone (αMSH) to regulate skin colour.46  286 
As well as mediating camouflage, skin colour also facilitates visual cues between 287 
conspecifics which allows individuals to mediate agonistic relationships while reducing costs 288 
to fitness. Under these circumstances, pigmentation is controlled by the hypothalamic-289 
pituitary-interrenal (HPI) axis which controls the physiological response to stress
47
. 290 
Endogenous glucocorticoids are therefore involved in controlling the aggregation and 291 
dispersal of melanin. Zebrafish mutants which lack functional GR show an impaired 292 
background adaptation response i.e. remain darker on a white background which coincides 293 
with an up-regulation of αMSH.48 Betamethasone17-valerate, a synthetic glucocorticoid, 294 
suppresses the pro-opiomelanocortin (POMC) transcript in wild type zebrafish, which is the 295 
precursor of αMSH. Corticotropin-releasing factor (CRF) is also involved in the control of 296 
melanin within the melanophores of zebrafish embryos.
49
 Therefore, exposure to synthetic 297 
glucocorticoids may alter skin pigmentation via changes to those hormones associated with 298 
regulating melanin transport and so exposure to 10 µg/l of prednisolone may mediate changes 299 
to skin colouration by altering HPI activity.  300 
 301 
While the aggregation of melanin is mediated by vision, the dispersal of melanin is regulated 302 
by photoreceptors found directly within the melanophores
34
. Exposure to 0.1 and 1 µg/l of 303 
prednisolone increased the area of dispersed melanin during the dark adaptation period but 304 
both treatments resembled controls after the first 20 minutes of the light adaptation period. 305 
This increase in dispersed melanin may be associated with changes to the photoreceptors 306 
within the melanophores. Alternatively, it could also be linked to the hypothesised changes to 307 
the HPI axis.  308 
 309 
Results from the LDBT show that control embryos prefer light over dark environments 310 
(Figure 4). Zebrafish embryos lose vision at night due to circadian control over retinal 311 
sensitivity
50
 and not due to the onset of darkness. Therefore the retina should remain active 312 
during the 3 hour dark adaptation period. However, zebrafish embryos do not yet possess 313 
functional rods within the retina
51
, which are responsible for vision during low light 314 
intensities
52
, and so while the retina may remain active, the embryos are functionally blind 315 
during this period. This could represent a significant stressor to embryos and a subsequent 316 
increase in circulating cortisol which may coincide with changes to melanogenic hormones. 317 
Differences between these lower concentrations of prednisolone and control embryos may 318 
also suggest that HPI functioning has been altered. Changes in the regulation of those 319 
hormones associated with the HPI axis may also be expected to significantly alter behaviour 320 
and may be linked to those observed changes in the LDBT.  321 
 322 
Overall, control embryos displayed a clear preference for the light compartment in the LDBT 323 
which is consistent with previous studies.
38,53-55
 However, the percentage of time embryos 324 
spent in the dark compartment was significantly altered in response to prednisolone (Figure 325 
4). Exposure to 0.1 µg/l of prednisolone significantly increased dark avoidance compared to 326 
controls, while 10 µg/l prednisolone of resulted in a significant increase in the preference for 327 
darkness. Given that the size of the pupils was not significantly different, nor were there any 328 
differences in lens opacity, the amount and quality of light entering the eye is not 329 
hypothesised to differ between treatments. However, changes to the organisation of the retina 330 
and altered photoreceptor development may alter the detection and conversion of light into 331 
chemical and electrical signals. Thompson et al.
36
 showed that mice which display reduced 332 
non-image-forming irradiance detection (Rpe65−/−) and which exhibit loss of rod and cone 333 
functionality (rd1), increase scotophobia during the LDBT. Yet, since embryos exposed to 334 
prednisolone displayed a light adaptation response in a manner consistent with controls, the 335 
processing of light cues appears to remain intact.  336 
 337 
Changes in the preference for either light or dark areas are more commonly associated with 338 
changes to neurological function and have become a popularised method to define the 339 
neurophenotype of individuals.
56
 Variation in how different individuals respond to such 340 
stimuli has led to the development of behavioural syndromes, which are defined as a 341 
collection of behavioural responses which are consistent over time and between different 342 
contexts.
57
 Several aspects of behaviour are used as indicators of behavioural syndromes, 343 
including anxiety
58
, which may occur in response to a perceived threat or in response to 344 
novelty
59
. However understanding the underlying motivations behind preference is complex 345 
and contrasting results between studies further confounds the interpretation of behaviour 346 
during the LDBT. While some studies have linked increased preference for darkness with 347 
increased levels of anxiety
60
, others have found a preference for brighter areas aids in 348 
alleviating stress
38
. Experimental conditions are therefore an important factor in interpreting 349 
preference (reviewed by Maximino et al.
37
).  In the present study, embryos were only 350 
acclimated for a 1 minute period and so individuals may have remained stressed during the 351 
LDBT since they were in a novel environment. Therefore, preference should reflect a strategy 352 
to help reduce anxiety.  353 
 354 
Control embryos spent 90% of their time within the light compartment which would suggest 355 
that avoiding dark areas helps to alleviate stress in this particular novel environment. 356 
Exposure to 0.1 µg/l of prednisolone significantly increased the proportion of time spent in 357 
the light compartment compared to controls, which would therefore suggest increased 358 
anxiety. In contrast, exposure to 1 and 10 µg/l of prednisolone reduced the proportion of time 359 
in the light compartment and may be interpreted as reduction in anxiety. Therefore, results 360 
suggest that prednisolone alters the preference for light and dark areas and may be associated 361 
with changes to neurological development. This could further implicate the HPI axis as a 362 
probable target of prednisolone toxicity. Anxiogenic compounds are known to induce 363 
behavioural responses synonymous with stress without simultaneously affecting multiple 364 
indices of anxiety.
60
 This may explain why activity and thigmotaxis did not vary between 365 
treatments during the LDBT in this study. Preference for light and dark areas may provide a 366 
more consistent measure of anxiety in response to synthetic glucocorticoid exposure. 367 
 368 
Exposure to the animated stimulus resulted in a significant change in position away from the 369 
moving image (Figure 5) which is consistent with Pelkowski et al.
39
 and Richendrfer and 370 
Créton
41
 who reported avoidance behaviour in response to visual stimuli during early life 371 
stages of zebrafish. No significant difference was found in the amount of time embryos spent 372 
away from the moving image between any of the concentrations of prednisolone tested 373 
however. Therefore, the ability to detect motion appears to be unaffected by prednisolone at 374 
these concentrations. Combined with evidence from the light adaption response and the 375 
LDBT, it is hypothesised that prednisolone does not alter vision in zebrafish embryos at 376 
environmentally relevant concentrations. Interestingly, results from the visual avoidance test 377 
would also suggest that embryos exposed to prednisolone respond to fear inducing stimuli in 378 
a manner similar to controls unlike during the LDBT, which triggered differences in 379 
behaviours associated with anxiety. Fear and anxiety are two distinct behavioural responses; 380 
while anxiety relates to perceived threat, fear is a response to an immediate risk. Both types 381 
of behavioural response utilise specific regions of the brain; the medial region of the dorsal 382 
pallium is believed to be the teleost equivalent of the mammalian amygdala which mediates 383 
fear responses, while the media habenula is associated with regulating behaviours indicative 384 
of anxiety.
59
 Therefore differences in anxiety but not fear may suggest specific neurological 385 
effects. 386 
 387 
Further studies should therefore attempt to investigate the neurological impact of 388 
prednisolone at environmentally relevant concentrations. Dexamethasone, another potent 389 
synthetic GR agonist, is known to down regulate GR expression in rainbow trout 390 
(Oncorhynchus mykiss) brains.
61
 Differences in mineralocorticoid receptor expression, which 391 
also bind glucocorticoids in teleosts, have also been shown to exist between individuals 392 
which display alternative behavioural phenotypes.
62
 Understanding the underlying molecular 393 
and physiological HPI response following prednisolone exposure may reveal possible 394 
underlying toxic mechanisms responsible for the observed changes to behaviour.  395 
 396 
In conclusion, exposure to environmentally relevant concentrations of prednisolone does not 397 
appear to affect the detection of light or the ability to detect motion. However, prednisolone 398 
exposure produced a darkened phenotype which coincided with a change in preference for 399 
darker environments. This change in pigmentation persisted within a light environment and 400 
suggests that this change may be maladaptive and may be associated with changes to the 401 
melanogenic system. If scototaxis is a reliable indicator of anxiety in embryos, this would 402 
suggest that prednisolone mimics the action of cortisol in adult zebrafish which predisposes 403 
individuals to different behavioural syndromes i.e. darker males are more aggressive
63
. 404 
Whether a reduction in anxiety and changes in skin pigmentation are also associated with 405 
changes in aggression and additional behavioural measures of copying style requires further 406 
attention. However, increased preference of dark environments is associated with boldness 407 
which tends to coincide with aggressiveness in fish.
58
 Differences between anxiety and fear 408 
responses also advocate neurological changes in specific regions of the developing brain. 409 
How and when such changes occur and how they may alter performance and survival now 410 
requires investigation.  411 
 412 
 413 
 414 
 415 
 416 
 417 
 418 
 419 
 420 
 421 
 422 
 423 
 424 
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Figure legends 622 
 623 
Figure 1: Photograph of an embryo at 96 hpf. Yellow line outlines the area analysed during 624 
light adaptation. Scale bar = 200 µm.  625 
 626 
Figure 2: Diagram of the avoidance response assay. Arrows denote the direction of each of 627 
the moving black bars and the dashed line marks the range of the animation.  628 
 629 
Figure 3: Area of pigmentation during light adaptation at 96 hpf (n = 12). Letters denote 630 
significant differences between treatments at specific time points (P < 0.05). Means ± SEM. 631 
 632 
Figure 4: Percentage of time spent in the dark area of the LDBT at 120 hpf (n = 12). Letters 633 
denote significant differences between treatments at specific time points (P < 0.05). Where 634 
bars share letters there is no significant difference. Means ± SEM.  635 
 636 
Figure 5: Time spent in the outer area of the well plate during the avoidance response assay 637 
in seconds at 144 hpf (n = 18). Asterisks denote significant differences between different time 638 
periods. Means ± SEM.   639 
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